Skip to main content
Caplight Logo









Biotts

Biotts

Private
Bielany WrocławskieHealthcare & Life Scienceshttps://biotts.com

Last Round

Accelerator

Oct 5, 2021

Total Funding Raised

$3.64M

Company Overview

Biotts is a Poland-based biotechnology company that develops proprietary drug delivery technologies and drug formulas in the fields of oncology, dermatology, and autoimmune diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical Devices

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

transdermal drug deliverydrug delivery platformtransdermal patchlarge molecule deliverynon-invasive drug deliverybiologic deliverydrug reformulationsustained drug releaseinsulin patchdiabetes treatmentobesity treatmenttransdermal insulindrug carrier technologyformulation developmentpain managementclinical stage biotechR&D services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Biotts Comparables

Compare Biotts with similar companies based on industry and business-model similarity.

Biotts comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Anodyne Nanotech
85%
Dyve Biosciences
79%
Axcelead, Inc.
77%

Biotts Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorOct 5, 2021
VC RoundMar 22, 2020
GrantDec 20, 2019
GrantAug 1, 2018

Key People

Founding team and executive leadership

Paweł Biernat

CTO

Executive Team

Biotts Investors

Notable investors and investment history

Biotts investors
InvestorRounds
Montis CapitalGrant
Google for Startups AcceleratorAccelerator
Montis CapitalVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 3, 2026

    Monthly visitors grew 152% MoM.

  • Mar 2, 2026

    Monthly visitors increased 282% MoM.

Biotts Filings

Explore SEC and related filing metadata, where available.

Biotts filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Firmographic Details

HeadquartersBielany Wrocławskie
Employee Range19
Year Founded2018
Last FundingOct 5, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?